OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Pennell on the Underutilization of Genetic Testing in Lung Cancer

October 30th 2019

Nathan A. Pennell, MD, PhD, discusses the underutilization of genetic testing in lung cancer.

Dr. Singh on Novel Therapies in Advanced Urothelial Cancer

October 29th 2019

Parminder Singh, MD, discusses the improvement in overall response rates with immunotherapy, targeted therapy, and antibody-drug conjugates in advanced urothelial cancer.

Dr. Patel on Immunotherapy Landscape of Stage IV NSCLC

October 29th 2019

Jyoti D. Patel, MD, discusses current immunotherapy options in stage IV non–small cell lung cancer.

Dr. Harrison on Subcutaneous Daratumumab and Isatuximab in Myeloma

October 29th 2019

Simon J. Harrison, MBBS, PhD, discusses the impact subcutaneous formulations of daratumumab and isatuximab could have in multiple myeloma.

Dr. Stadtmauer Discusses Promising Targets in Multiple Myeloma

October 29th 2019

Edward A. Stadtmauer, MD, section chief, Hematologic Malignancies, and Roseman, Tart, Harrow, and Shaffer Families’ President’s Distinguished Professor, Penn Medicine, University of Pennsylvania, discusses promising targets in multiple myeloma.

Dr. Robson Discusses the Driving Force Behind Biosimilar Use in Oncology

October 29th 2019

Mark E. Robson, MD, chief, Breast Medicine Service, Memorial Sloan Kettering Cancer Center, discusses the driving force behind biosimilar use in oncology.

Dr. Agarwal on the QoL With Apalutamide in Metastatic Castration-Sensitive Prostate Cancer

October 29th 2019

Neeraj Agarwal, MD, associate professor of medicine, University of Utah School of Medicine; and director, Genitourinary Oncology Program, Oncology Division, co-leader, Urologic Oncology Multidisciplinary Program, associate director of Clinical Trials, Huntsman Cancer Institute, University of Utah, discusses quality of life (QoL) with apalutamide (Erleada) in the treatment of patients with metastatic castration-sensitive prostate cancer.

Dr. Segal on Next-Generation Sequencing for Lung Cancer

October 28th 2019

Jeremy Segal, MD, PhD, discusses the use of next-generation sequencing for patients with lung cancer.

Targeting Wnt in BRAF-Mutant Colorectal Cancer

October 28th 2019

Luke Dow, PhD, discusses phase I trials targeting the Wnt signaling pathway in colorectal cancer.

Dr. Choi on Using Low-Dose CT Scans to Screen for Lung Cancer

October 26th 2019

Humberto Choi, MD, discusses using low-dose CT scans to screen patients with a high-risk of developing lung cancer.

Dr. Corcoran on Immunotherapy for Microsatellite Stable/Instable CRC

October 26th 2019

Ryan B. Corcoran, MD, PhD, discusses immunotherapy options for patients with microsatellite stable versus microsatellite instability–high colorectal cancer.

Dr. Sonpavde on Neoadjuvant Immunotherapy in Bladder Cancer

October 26th 2019

Guru P. Sonpavde, MD, discusses current neoadjuvant immunotherapy options in bladder cancer based on cisplatin eligibility status.

Dr. Waxman on Selinexor in Multiple Myeloma Treatment

October 25th 2019

Adam J. Waxman, MD, MS, discusses the STORM trial and using selinexor to treat patients with multiple myeloma.

Dr. Koo on Next-Generation Imaging in Prostate Cancer

October 25th 2019

Phillip J. Koo, MD, discusses next-generation imaging tools in prostate cancer.

Dr. Benson on Sequencing Strategies with Cetuximab in CRC

October 25th 2019

Al B. Benson, MD, discusses the optimal sequencing of the EGFR inhibitor cetuximab for patients with RAS wild-type colorectal cancer.

Dr. Wierda on the ASCEND Trial and BTK Inhibitor-Based Therapies in CLL

October 25th 2019

William G. Wierda, MD, PhD, discusses the use of BTK inhibitors in chronic lymphocytic leukemia.

Dr. Weber on the Future of Checkpoint Inhibitors in Melanoma

October 25th 2019

Jeffrey S. Weber, MD, PhD, discusses the future of checkpoint inhibitors in melanoma.

Dr. Ng on Immunotherapy in Micrometastatic High-Risk Soft Tissue Sarcoma

October 25th 2019

Vincent Y. Ng, MD, discusses immunotherapy in micrometastatic high-risk soft tissue sarcoma.

Dr. Bhatt on Finding a PD-L1 Pathway of Resistance in RCC

October 25th 2019

Rupal S. Bhatt, MD, PhD, discusses the potential identification of a pathway of resistance for PD-L1 in renal cell carcinoma.

Dr. Cho on Investigational BiTE Therapies in Multiple Myeloma

October 25th 2019

Hearn Jay Cho, MD, PhD, discusses investigational bispecific T-cell engager therapies in multiple myeloma.